Cavernous Malformations of Central Nervous System in Pediatric Patients: Our Single-centered Experience in 50 Patients and Review of Literature
Overview
Authors
Affiliations
Purpose: Cavernous malformations (CMs) are rare developmental cerebrovascular malformations of the central nervous system with a childhood prevalence of 0.3 to 0.53%. Our purpose was to assess the clinical features and microsurgical outcome in pediatric central nervous system (CNS) CMs.
Material And Methods: We retrospectively enrolled all the CM patients admitted to our institute from 1 January 2001 to 31 December 2014. Data was analyzed for their clinical features and surgical outcome.
Results: A total of 50 patients with CMs (30 supratentorial, 14 infratentorial, and 6 spinal) with a mean age of 14 years (3-18 years, SD ±4.64) were enrolled into the study. Most of these patients (78%) were male. Size varied from 1.2 to 6 cm. Three patients had multiple CMs. Symptoms of CMs were site specific. Seizure was the most common symptom (63.3%) of CMs at supratentorial location followed by headache (46%) and neurodeficiency (26%), while all brainstem and spinal CMs presented with neurodeficiencies. History of clinically significant acute hemorrhage was present in 19.2% of supratentorial (ST) superficial CMs, 50% of ST deep CMs, 25% of cerebellar CMs, 44.4% of brainstem CMs, and 50% of spinal CMs. Forty-five CMs in 44 patients were surgically excised. Their follow-up ranged from 6 to 162 months (mean 47.2 months, SD ±53). All supratentorial CM patients showed improvement in their symptoms. Patients with preoperative seizure showed good seizure control with Engel scale I in 16 (94.1%) and Engel scale II in 1 (5.9%). In infratentorial (IT) and spinal CM patients, 92.3 and 66.7% had improvement in their neurodeficiencies, respectively. There was no mortality in our series.
Conclusion: Microsurgical excision of CNS CM results in excellent neurological outcome in pediatric patients. Early intervention is necessary in spinal CMs for better outcome.
Kasriel E, Boecher-Schwarz H, Scalais E Cureus. 2024; 16(8):e67525.
PMID: 39310532 PMC: 11416157. DOI: 10.7759/cureus.67525.
Outcomes after surgical and nonsurgical treatment of pediatric cerebral cavernous malformation.
Zhang H, Yu Q, Mao Z, Zhang L, Yu X Pediatr Investig. 2024; 8(2):126-134.
PMID: 38910851 PMC: 11193375. DOI: 10.1002/ped4.12435.
Sordyl R, Antkowiak L, Rogalska M, Schroter M, Rosol I, Ciekalski M Childs Nerv Syst. 2024; 40(8):2443-2448.
PMID: 38713207 PMC: 11269512. DOI: 10.1007/s00381-024-06433-5.
Giant brainstem cavernoma in pediatrics: diagnosis and treatment-case report.
Badaloni M, Gonzalez Ramos J Childs Nerv Syst. 2024; 40(6):1957-1960.
PMID: 38451297 DOI: 10.1007/s00381-024-06347-2.
Functional outcome after pediatric cerebral cavernous malformation surgery.
Rauschenbach L, Santos A, Dinger T, Oppong M, Li Y, Tippelt S Sci Rep. 2023; 13(1):2286.
PMID: 36759693 PMC: 9911771. DOI: 10.1038/s41598-023-29472-5.